New England Life Care, Inc., dba Advanced Compounding Solutions

FDA inspection history across 2 sites, 2017 to 2023

2
Warning letters
2
Form 483s
1
Response

Every document, by year

  • Warning letter
  • Form 483
  • Response

2017: one 483 response and one Form 483; 2019: one warning letter; 2022: one Form 483; 2023: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017–19One 483 response, one Form 483 and one warning letter, at Woburn, Massachusetts and Massachusetts.
  2. 2022–23One Form 483 and one warning letter, at Woburn, Massachusetts.
  3. 2022The longest 483 on file: 7 observations over 13 pages at Woburn, Massachusetts.

Cited most

Across all New England Life Care, Inc., dba Advanced Compounding Solutions observations on file

The complete New England Life Care, Inc., dba Advanced Compounding Solutions file.

All 5 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$506$595

15% off buying them one by one

Sites

Documents

5 on file, newest first
DateDocumentPrice
2023-05-16Warning letter Warning letter$99
2022-04-28483 Form 483$99
2019-08-21Warning letter Warning letter$99
2017-09-29Response 483 response$199
2017-08-22483 Form 483$99

FEI number 3010371376 · most recent document May 16, 2023

About New England Life Care, Inc., dba Advanced Compounding Solutions

How many FDA Form 483s has New England Life Care, Inc., dba Advanced Compounding Solutions received?

FDA Intel has 2 Form 483s on file for New England Life Care, Inc., dba Advanced Compounding Solutions; the most recent is dated Apr 28, 2022.

When was New England Life Care, Inc., dba Advanced Compounding Solutions last inspected by FDA?

The most recent FDA inspection document on file for New England Life Care, Inc., dba Advanced Compounding Solutions is a Form 483 dated Apr 28, 2022, for the site in Woburn, Massachusetts.

What did FDA cite at New England Life Care, Inc., dba Advanced Compounding Solutions?

The regulations cited most in the observations on file for New England Life Care, Inc., dba Advanced Compounding Solutions are 21 CFR 211.113 (Control of microbiological contamination), 3 times; 21 CFR 211.42 (Design and construction features), 3 times; 21 CFR 211.134 (Drug product inspection), 1 time.

Has New England Life Care, Inc., dba Advanced Compounding Solutions received an FDA warning letter?

Yes. FDA Intel has 2 FDA warning letters on file for New England Life Care, Inc., dba Advanced Compounding Solutions; the most recent is dated May 16, 2023.